Skip to main content
Premium Trial:

Request an Annual Quote

Trinean DropSense96

Trinean has launched a new DropSense96 platform, a UV/VIS reader. Like the older model, the reader can still analyze 1 to 96 samples in a single experiment. The updated platform offers a significant increase of the sensitivity which allows quantification of a broader range of native samples through the company's cDrop software. The software now includes broad-use-extraction kit independent application to detect contaminants in any DNA, RNA, or protein samples. It corrects concentration determination accordingly. The cDrop software enhances the user experience and allows for better assessment of sample quality and fitness for downstream analysis, the company said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.